Continuing Medical Education Information


Continuing Medical Education Information

The goal of the 2014 ASCO Annual Meeting is to foster communication among oncology-related subspecialties and the exchange of a wide range of ideas related to cancer. ASCO's objectives are to advance the education of physicians and other professionals caring for patients with cancer, to support the development of clinical cancer researchers, and to facilitate the delivery of high-quality health care to patients with cancer. The 2014 ASCO Annual Meeting is designed to serve the respective interests of the Society's multidisciplinary membership, with education focused on medical, surgical, and radiation oncology

2014 Annual Meeting General Accreditation Information

The American Society of Clinical Oncology (ASCO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This live activity has been approved for 46.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All nonphysician attendees are welcome to submit a request for a Certificate of Participation, which may enable nonphysicians to apply their Annual Meeting participation toward re-licensure.

Any questions related to CME may be directed to ASCO Staff at or 571-483-1403.

Needs Statement

With emerging educational and scientific advances, oncology is a field where patient care standards can change very quickly. Due to the high volume of literature and best practices information available, it is important that oncologists and other cancer care providers synthesize and digest the latest evidence based information applicable to their practice/research setting.

In an effort to meet educational needs based on this rapid exchange of information, ASCO is committed to disseminating the latest scientific findings in oncology and practice-changing advances in cancer prevention, diagnosis, treatment, and survivorship.

Target Audience

The Annual Meeting is designed for U.S. and international physicians and researchers involved in multidisciplinary clinical cancer care including, but not limited to medical, surgical, and radiation oncologists; pathologists; radiologists; and other translational-oriented laboratory scientists.

The Annual Meeting can also benefit nurses, pharmacists, physician assistants, and other health care professionals involved in clinical cancer care and cancer research.

Learning Objectives

Upon participation in this activity, attendees will be able to:

  • Examine scientific advances that further enhance knowledge of cancer biology and pathogenesis
  • Incorporate knowledge gained pertaining to advances in clinical cancer research into innovative management strategies and trail designs to improve patient outcomes
  • Review recent and emerging data from key studies in clinical cancer research
  • Evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of people with cancer
  • Implement clinical and scientific strategies designed to improve the quality of cancer care, as appropriate
  • Effectively communicate with colleagues and with patients regarding advances in clinical oncology science
  • Identify and utilize tools for cancer risk assessment and risk reduction based on the best available evidence
  • Collaborate across different specialties and with all members of the patient care team to provide the most effective treatment for patients with cancer

This activity was planned in the context of the following ACGME competencies: Patient Care, Medical Knowledge, Practice-based Learning and Improvement, Interpersonal and Communication Skills, Professionalism, and Systems-based Practice.

Annual Meeting Educational Supporters

ASCO and the Conquer Cancer Foundation gratefully acknowledge the organizations listed in the Meeting Supporters page for supporting the education of the Annual Meeting. 

 Unlabelled Usage Statement

The information presented is that of the contributing faculty and does not necessarily represent the views of the American Society of Clinical Oncology and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty presenters. Therefore, before prescribing any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions and adverse effects.